News for Appili Therapeutics Inc. (APLIF)

Aditxt, Inc. (ADTX) has terminated its Arrangement Agreement with Appili Therapeutics, Inc. to eliminate approximately $16 million in closing obligations.

\nAditxt, Inc. (NASDAQ: ADTX) (\

Aditxt, Inc. (NASDAQ: ADTX) (”œAditxt” or the ”œCompany”), a social innovation platform accelerating promising health innovations, announced that today's

Aditxt, Inc. (NASDAQ: ADTX), (”œAditxt” or the ”œCompany”), a social innovation platform accelerating promising health innovations, announced that today'

Four new funding proposals, totalling US$117.5 million, have been submitted for reviewModifications received to U.S. Air Force Academy Cooperative AgreementOuts

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation platform dedicated to discovering, developing, and deploying promising health innovation

Aditxt, Inc. (NASDAQ: ADTX) (”œAditxt” or the ”œCompany”), an innovation platform dedicated to discovering, developing, and deploying promising health in

Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on

Received overwhelming shareholder support in favour of take-private transaction with Aditxt

ADTX stock plunges to 52-week low, touches $0.18

Aditxt, Inc. (NASDAQ: ADTX) (”œAditxt” or the ”œCompany”), a social innovation platform dedicated to accelerating promising health innovations, today ann

Overwhelming shareholder support in favour of take-private transaction with Aditxt

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024

HALIFAX, Nova Scotia, Oct. 10, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), announces correction to it…

Aditxt moves to acquire Appili Therapeutics

Aditx Therapeutics stock hits 52-week low at $1.58

MOUNTAIN VIEW, Calif. — Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), an innovation platform dedicated to discovering, developing, and deploying promisi…

Aditxt shareholders approve strategic proposals